Twist Bioscience Announces Closing of Upsized Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
Twist Bioscience Corporation (TWST)
Last twist bioscience corporation earnings: 2/6 04:05 pm
Check Earnings Report
Company Research
Source: Business Wire
SAN FRANCISCO--(BUSINESS WIRE)-- Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced the closing of its upsized underwritten public offering of 4,312,500 shares of its common stock at a public offering price of $21.00 per share, which includes the exercise in full by the underwriters of their option to purchase up to an additional 562,500 shares of common stock in this offering. Twist estimates net proceeds from the offering to be approximately $84.1 million, after deducting underwriting discounts and commissions and estimated offering expenses. J.P. Morgan Securities LLC, Cowen and Company, LLC and Evercore Group L.L.C. acted as joint book-running managers for the offering. Robert W. Baird & Co. Incorporated acted as lead manager. A registration statement relating to th
Show less
Read more
Impact Snapshot
Event Time:
TWST
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TWST alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TWST alerts
High impacting Twist Bioscience Corporation news events
Weekly update
A roundup of the hottest topics
TWST
News
- Twist Bioscience to Report Fiscal 2024 Second Quarter Financial Results on Thursday, May 2, 2024Business Wire
- Twist Bioscience Co. (NASDAQ: TWST) had its price target lowered by analysts at Barclays PLC from $45.00 to $40.00. They now have an "overweight" rating on the stock.MarketBeat
- Despite shrinking by US$135m in the past week, Twist Bioscience (NASDAQ:TWST) shareholders are still up 132% over 1 year [Yahoo! Finance]Yahoo! Finance
- Twist Bioscience Launches Pangenome Spike-in Exome Panel to Enable Advancement of Research for Diverse Populations [Yahoo! Finance]Yahoo! Finance
- Twist Bioscience Launches Pangenome Spike-in Exome Panel to Enable Advancement of Research for Diverse PopulationsBusiness Wire
TWST
Earnings
- 2/2/24 - Beat
TWST
Sec Filings
- 4/11/24 - Form 4
- 4/9/24 - Form 144
- 4/4/24 - Form 4
- TWST's page on the SEC website